Study: FDG-PET scans may lead to misdiagnosis of Alzheimer's

04/26/2012 | Medscape (free registration)

Sixty-five percent of patients in a community setting had a misdiagnosis or inconclusive data after an FDG-PET scan for Alzheimer's disease, with 35% having false-positive results, according to a study presented at a neurology meeting. The study indicates a need to standardize protocols for reading results, an expert said. Another expert has expressed concern over the findings, particularly with the arrival of new PET tracers for Alzheimer's.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR